The impact of clinical pharmacist support on patients receiving multi-drug therapy for coronary heart disease in China

Indian Journal of Pharmaceutical Sciences

Volumn 77, Issue 3, 2015, Pages 306-311

  Zhao, S J ^a   Zhao, H W ^a   Du, S ^a   Qin, Y H ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

clinical pharmacy service; Coronary heart disease; pharmacist; quality of life

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; CHINA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENTION TO TREAT ANALYSIS; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TELEPHONE INTERVIEW;

EID: 84936133500     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.159632     Document Type: Article

References (16)

1. Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm 2013;19:408-16.
2. Cai H, Dai H, Hu Y, Yan X, Xu H. Pharmacist care and the management of coronary heart disease: A systematic review of randomized controlled trials. BMC Health Serv Res 2013;13:461.
3. Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS. Cardiac rehabilitation patient and organizational factors: What keeps patients in programs? J Am Heart Assoc 2013;2:e000418.
4. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003;25:144-53.
5. Liu X, Yang M, Zhang X. Clinical pharmacist work patterns and case analysis in department of cardiology. Chin J Hosp Pharm 2012;32:975-7.
6. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
7. National Collaborating Centre for Primary Care (UK). Post Myocardial Infarction: Secondary prevention in primary and secondary care for patients following a myocardial infarction. London (UK): Royal College of General Practitioners; 2007.
8. Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: A randomized trial. Am Heart J 2012;163:657-65. e1.
9. Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, et al. Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. AMIA Annu Symp Proc 2006;10:850.
10. Pham V, Jeffe DB, Noirot LA, Dunagan WC, Reichley RM, Bailey TC. Physicians' knowledge and attitudes about coronary heart disease secondary prevention. AMIA Annu Symp Proc 2007;11:1076.
11. Zhang X, Yang G. The effect of medication reconciliation in patients with medication errors in cardiology department. Chin Pharm J 2013;48:234-7.
12. Kovacs AH, Moons P. Psychosocial functioning and quality of life in adults with congenital heart disease and heart failure. Heart Fail Clin 2014;10:35-42.
13. Michal M, Simon P, Gori T, König J, Wild PS, Wiltink J, et al. Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: Study protocol for a randomized controlled trial of feasibility and effects. Trials 2013;14:314.
14. Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol 2013;61:1607-15.
15. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909-17.
16. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.